Diagnostic value of faecal calprotectin in paediatric gastroenterology clinical practice

Digestive and Liver Disease

Volumn 36, Issue 7, 2004, Pages 467-470

  Canani, R Berni ^a   Rapacciuolo, L ^a   Romano, M T ^a   De Horatio, L Tanturri ^a   Terrin, G ^a   Manguso, F ^a   Cirillo, P ^a   Paparo, F ^a   Troncone, R ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Functional bowel disorders; Gut inflammation; Inflammatory bowel diseases

Indexed keywords

ANTIBIOTIC AGENT; CALPROTECTIN; NONSTEROID ANTIINFLAMMATORY AGENT; BIOLOGICAL MARKER; CALGRANULIN;

ABDOMINAL PAIN; ADOLESCENT; ADULT; ANAMNESIS; ARTICLE; CALCULATION; CHILD; CHRONIC DISEASE; CLINICAL OBSERVATION; CLINICAL PRACTICE; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIARRHEA; DIFFERENTIAL DIAGNOSIS; DIGESTIVE SYSTEM INFLAMMATION; ENTERITIS; ENTEROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPISTAXIS; FECES ANALYSIS; FEMALE; GASTROENTEROLOGY; GASTROINTESTINAL DISEASE; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL MUCOSA; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MENSTRUAL CYCLE; PATIENT REFERRAL; PEDIATRICS; RECEIVER OPERATING CHARACTERISTIC; RESPIRATORY TRACT INFECTION; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY; CHEMISTRY; FECES; INFLAMMATION; PRESCHOOL CHILD;

ADOLESCENT; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FECES; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; INFANT; INFLAMMATION; LEUKOCYTE L1 ANTIGEN COMPLEX; MALE;

EID: 4444320724     PISSN: 15908658     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.dld.2004.02.009     Document Type: Article

References (17)

1. Limburg PJ, Ahlquist DA, Sandborn WJ, Mahoney DW, Devens ME, Harrington JJ, et al. Faecal calprotectin levels predict colorectal inflammation among patients with chronic diarrhoea reffered for colonoscopy. Am J Gastroenterol 2000;95:2831-7.
2. Roseth AG. Determination of faecal calprotectin, a novel marker of organic gastrointestinal disorders. Dig Liver Dis 2003;35:607-9.
3. Costa F, Mumolo MG, Bellini M, Romano MR, Ceccarelli L, Arpe P, et al. Role of faecal calprotectin as non-invasive marker of intestinal inflammation. Dig Liver Dis 2003;35:642-7.
4. Olafsdottir E, Askens L, Fluge G, Berstad A. Faecal calprotectin levels in infants with infantile colic, healthy infants, children with inflammatory bowel disease, children with recurrent abdominal pain and healthy children. Acta Pediatr 2002;91:45-50.
5. Tibble J, Smale S, Bjarnason I. Value of intestinal function tests in inflammatory bowel disease. Inflammatory Bowel Disease Monitor 2000;4:99-103.
6. Aadland E, Fagerhol MK. Faecal calprotectin: a marker of inflammation throughout the intestinal tract. Eur J Gastroenterol Hepatol 2002;14:823-5.
7. Bunn SK, Bisset WM, Main MJC, Golden BE. Faecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2001;32:171-7.
8. Bunn SK, Bisset WM, Main MJC, Gray ES, Olson S, Golden BE. Faecal calprotectin: validation as a non-invasive measure of bowel inflammation in childhood inflammatory bowel disease. J Pediatr Gastroenterol Nutr 2001;33:14-22.
9. Miner PB. Clinical features, course, laboratory findings, and complications in ulcerative colitis. In Inflammatory bowel disease (fifth edition). Edited by Kirsner JB 2000;18:299-304.
10. Stern M. Allergic enteropathy/Food Allergy. In Paediatric Gastrointestinal Disease. Edited by Walker, Durie, Hamilton, Walker-Smith, Watkins 2000;45:746-62.
11. Green PHR, Jabri B. Coeliac disease. Lancet 2003;362:383-91.
12. Rasquin-Weber A, Hyman PE, Cucchiara S, Fleissher DR, Hyams S, Milla PJ, et al. Chilhood functional gastrointestinal disorders. Gut 1999;45:II60-8.
13. Fagerberg UL, Loof L, Merzoug RD, Hansson LO, Finkel Y. Faecal calprotectin levels in healthy children studied with an improved assay. J Pediatr Gastroenterol Nutr 2003;37:468-72.
14. Beattie RM, Nicholls SW, Domizio P. Endoscopic assessment of the colonic response to corticosteroids in children with ulcerative colitis. J Pediatr Gastroentrol Nutr 1996;22:373-9.
15. Sandborn WJ, Faegan BG, Hanauer SB, Lochs H, Lofberg R, Modigliani R, et al. A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. Gastroenterology 2002;122:512-30.
16. Holmquist L, Ahren C, Fallstrom SP. Clinical disease activity and inflammatory activity in the rectum in relation to mucosal inflammation assessed by colonoscopy. A study of children and adolescents with chronic inflammatory bowel disease. Acta Paediatr Scand 1990;79:527-34.
17. Tibbie JA, Sigthorsson G, Foster R, Forgacs I, Bjarnason . Use of surrogate markers of inflammation and Rome criteria to distinguish organic from non-organic intestinal disease. Gastroenterology 2002;123:450-60.